cox19 Antibody

What is COX19 and why is it a significant target for antibody-based research?

COX19 belongs to the twin Cx9C protein family located in the intermembrane space (IMS) of mitochondria. It serves as a critical interaction partner of Cox11, a copper transfer protein essential for proper copper insertion into cytochrome c oxidase (CcO) . Studies demonstrate that COX19 is necessary for CcO biogenesis in humans, with COX19 knockout cells showing complete loss of holo-CIV (fully assembled cytochrome c oxidase), absence of CcO activity, and elimination of cellular respiration . Beyond its role in CcO assembly, COX19 also functions in the transduction of a SCO1-dependent mitochondrial redox signal that regulates ATP7A-mediated cellular copper efflux .

Antibodies against COX19 enable researchers to investigate these complex biochemical pathways through techniques such as immunoprecipitation, western blotting, and immunofluorescence. The significance of COX19 in both mitochondrial function and cellular copper homeostasis makes it an important target for researchers studying respiratory chain disorders, copper metabolism diseases, and related mitochondrial pathologies.

How can researchers validate the specificity of COX19 antibodies?

Validating antibody specificity is critical for reliable experimental outcomes. For COX19 antibodies, a multi-faceted approach is recommended:

• Knockout validation: Generate COX19-knockout cell lines using CRISPR-Cas9, as demonstrated in HEK293T cells in published studies . Compare antibody reactivity in wild-type versus knockout cells via western blot, with absence of signal in knockout cells confirming specificity.

• Overexpression controls: Transfect cells with a COX19 expression construct containing an orthogonal tag (e.g., Myc-DDK-tagged COX19) . Verify co-localization of signals from both the COX19 antibody and the tag-specific antibody.

• RNAi approaches: Implement stable knockdown of COX19 using specific miRNA or shRNA (e.g., "D3" shRNA) . Reduced signal intensity proportional to knockdown efficiency supports antibody specificity.

• Cross-reactivity assessment: Test the antibody against recombinant proteins with structural similarity to COX19, particularly other twin Cx9C proteins from the mitochondrial intermembrane space, to rule out cross-reactivity.

Researchers should always include appropriate positive and negative controls in their experimental design and document antibody validation in publications to enhance reproducibility.

How can COX19 antibodies be optimized for immunoprecipitation studies of protein-protein interactions?

COX19 participates in critical protein interactions, particularly with Cox11, that regulate copper insertion into cytochrome c oxidase. Optimizing immunoprecipitation (IP) protocols for studying these interactions requires special considerations:

For copper-containing complexes, extract from purified mitochondria under native conditions without crosslinkers before immunoprecipitation to allow for subsequent metal analysis by ICP-MS .

What experimental approaches can detect redox-dependent changes in COX19 function?

COX19's involvement in redox-regulated processes makes studying its redox state critical for understanding its function. Several approaches can be implemented:

• Non-reducing versus reducing SDS-PAGE: Compare COX19 migration patterns under reducing and non-reducing conditions to detect intramolecular disulfide bonds that affect protein conformation.

• Cysteine-to-alanine mutagenesis: Generate COX19 variants with cysteine-to-alanine substitutions in conserved Cx9C motifs to identify specific residues involved in redox sensing or regulation . The twin Cx9C motifs likely play a role in redox monitoring of SCO1's functional status .

• Hydrogen peroxide sensitivity assays: Assess cellular sensitivity to hydrogen peroxide in COX19 knockout or mutant cell lines. The phenotypic similarity between Cox11 and Cox19 deletion mutants in yeast regarding hydrogen peroxide sensitivity suggests functional connection in oxidative stress response pathways .

• Subcellular fractionation analysis: Monitor changes in COX19 distribution between mitochondria and cytosol under different redox conditions, as altered localization may be part of its regulatory mechanism .

• Proximity-based labeling: Use techniques like BioID or APEX2 fused to COX19 to identify proximal proteins under various redox conditions, potentially revealing redox-dependent interaction networks.

When designing these experiments, researchers should consider that the relative subcellular distribution of COX19 appears critical to the transduction of mitochondrial redox signals that regulate cellular copper efflux .

What methodological considerations are important when using COX19 antibodies in knockout/mutation studies?

When using COX19 antibodies in knockout or mutation studies, several methodological considerations ensure reliable results:

• Proper knockout validation: Verify knockout efficiency using multiple techniques beyond immunoblotting, including genomic sequencing of the targeted locus . The search results describe sequencing of the COX19 locus using specific oligonucleotides (COX19-Forward and COX19-Reverse) .

• Complementation controls: Include rescue experiments by reintroducing wild-type COX19 to confirm phenotypic effects are directly attributable to COX19 absence rather than off-target effects . Tagged versions (e.g., Myc-DDK-tagged) under control of truncated Δ5-CMV promoters have been successfully used.

• Monitoring associated proteins: In COX19 knockout studies, examine levels of functionally related proteins (COX17, COX23, PET191) as these show compensatory changes in expression . This helps establish the broader cellular response to COX19 deficiency.

• Functional assays: Include measurements of cytochrome c oxidase activity, respiration capacity, and copper content when assessing COX19 knockout phenotypes . COX19-KO lines show complete loss of holo-CIV assembly, CcO activity, and cellular respiration.

• Age of cultures: Consider the time point of analysis post-knockout, as compensatory mechanisms may develop over time that mask acute phenotypes.

For mutation studies, site-directed mutagenesis targeting conserved cysteine residues in the twin Cx9C motifs has been particularly informative . Expression constructs can be generated using established molecular techniques such as the Q5® Site-Directed Mutagenesis Kit, with subsequent transfection into knockout cell lines to assess functional rescue .

What are the optimal conditions for using COX19 antibodies in Western blot analysis?

Achieving optimal Western blot results with COX19 antibodies requires attention to several technical parameters:

• Sample preparation: Extract mitochondrial proteins using mild detergents that preserve protein integrity. For total cell lysates, differential centrifugation techniques to enrich mitochondrial content improve detection sensitivity.

• Gel selection: Use 12-15% polyacrylamide gels to resolve COX19 effectively, as it is a relatively small protein. Gradient gels (4-20%) can also be employed for simultaneous analysis of COX19 and its larger interaction partners.

• Transfer conditions: Implement wet transfer at 100V for 1 hour or 30V overnight in transfer buffer containing 20% methanol for efficient transfer of small proteins like COX19.

• Blocking parameters: Block with 5% non-fat dry milk in TBST for 1 hour at room temperature. For phospho-specific detection, substitute with 5% BSA in TBST.

• Antibody dilution: Primary COX19 antibody dilutions typically range from 1:500 to 1:2000, though optimal dilution should be determined empirically for each antibody lot. Incubate overnight at 4°C for maximum sensitivity.

• Detection method: Enhanced chemiluminescence (ECL) systems provide good sensitivity, but for quantitative analysis of subtle changes in COX19 levels (as seen in some genetic backgrounds ), fluorescence-based detection offers superior linearity.

• Controls to include: Always run wild-type, knockout, and overexpression samples as positive and negative controls. Additionally, include a mitochondrial loading control such as VDAC or TOM20 to normalize for mitochondrial content.

For studying dynamic COX19-Cox11 interactions, non-reducing conditions may be important to preserve disulfide bonds that could mediate these interactions .

How can researchers detect and analyze changes in COX19 subcellular localization?

COX19's function appears influenced by its subcellular distribution between mitochondria and cytosol . Multiple complementary approaches can effectively track these localization patterns:

• Subcellular fractionation protocol:

  • Homogenize cells in isotonic buffer (250 mM sucrose, 10 mM HEPES-KOH pH 7.4, 1 mM EDTA)

  • Centrifuge at 800g for 10 minutes to remove nuclei

  • Centrifuge supernatant at 10,000g for 15 minutes to pellet mitochondria

  • Ultracentrifuge resulting supernatant at 100,000g for 1 hour to separate cytosol

  • Analyze fractions by immunoblotting for COX19 and compartment markers

• Immunofluorescence microscopy:

  • Fix cells in 4% paraformaldehyde for 15 minutes

  • Permeabilize with 0.2% Triton X-100 for 5 minutes

  • Block with 3% BSA in PBS for 1 hour

  • Co-stain with COX19 antibody and mitochondrial markers (e.g., TOMM20)

  • Use super-resolution microscopy for precise colocalization analysis

• Live-cell imaging approaches:

  • Generate COX19-fluorescent protein fusions (ensuring functionality)

  • Co-express with organelle-specific markers

  • Monitor localization changes in response to experimental stimuli (oxidative stress, copper depletion/supplementation)

• Protease protection assays:

  • Isolate intact mitochondria from cells

  • Treat with proteinase K under various conditions (intact mitochondria, hypotonic swelling, detergent permeabilization)

  • Analyze COX19 protection patterns to determine submitochondrial localization

When analyzing subcellular localization data, quantify the relative distribution between compartments and correlate changes with functional outcomes like cellular copper levels, which have been shown to decrease upon COX19 knockdown .

What are the key considerations when using COX19 antibodies to study mitochondrial copper homeostasis?

COX19's role in copper homeostasis presents unique considerations when using antibodies for related studies:

• Copper supplementation controls: Include experimental conditions with copper supplementation (e.g., 1.5 mM Cu-His, 1 mM CuCl₂, or 1 nM elesclomol + 1 mM CuCl₂) to assess COX19 response to varying copper levels.

• Metal detection methods: Combine immunoprecipitation using COX19 antibodies with ICP-MS analysis to quantify copper associated with COX19-containing complexes . This approach has successfully demonstrated copper binding to complexes containing wild-type COX11 but not mutant variants.

• Co-detection strategies: Implement co-immunoprecipitation followed by immunoblotting to detect interactions between COX19 and other copper homeostasis proteins (SCO1, SCO2, COX11). Studies show altered interactions between these proteins affect copper binding .

• Quantitative copper measurements: Correlate COX19 levels/localization with total cellular copper content as measured by atomic absorption spectroscopy or other quantitative methods. COX19 knockdown has been shown to significantly reduce cellular copper levels .

• Redox state monitoring: Consider the redox environment when studying COX19's role in copper homeostasis, as the protein's function in copper regulation appears to be redox-dependent .

• Co-expression experiments: Design co-expression studies of COX19 with other copper-handling proteins (COX17, SCO1, SCO2) to assess synthetic interactions . Such approaches have been implemented by co-transfecting expression constructs followed by selection of stable cell lines.

When designing these experiments, recognize that COX19's role in copper homeostasis extends beyond CcO assembly to broader cellular copper efflux regulation, making it important to assess both mitochondrial and cellular copper parameters .

How do COX19 mutations affect protein-protein interactions and downstream pathways?

The impact of COX19 mutations on protein interaction networks reveals much about its functional mechanisms:

• Interaction network alterations: COX19 deficiency affects the steady-state levels of other twin Cx9C proteins, with COX19 and COX23 levels reduced and COX17 and PET191 levels increased in SCO patient cells . This suggests a complex regulatory network that responds to COX19 status.

• Impact on metallochaperone complexes: In the absence of COX19, metallochaperone modules containing COX11 show impaired copper binding capacity. ICP-MS analysis reveals that complexes containing wild-type COX11 bind significant amounts of copper, while those from COX19-deficient cells show no detectable bound copper .

• Accumulation of stalled assembly intermediates: COX19 mutations lead to the accumulation of assembly intermediates containing COX1 but lacking COX2 . These intermediates (labeled S1-S4) resemble those seen in cells with mutations affecting COX2 incorporation or metalation.

• Altered interactions with assembly factors: Mutations in COX11 that prevent COX19 accumulation result in increased interactions with assembly factors like COA6, COX16, COX17, PET191, COA3, and particularly SURF1 . This suggests COX19 normally regulates the progression of assembly complexes.

• Functional consequences: COX19 knockout results in complete loss of fully assembled cytochrome c oxidase (CIV), CcO activity, and cellular respiration . In contrast, COX11 knockout allows some residual CcO assembly (15%) and respiratory capacity (60%), indicating distinct but overlapping functions.

Studies utilizing site-directed mutagenesis to generate cysteine-to-alanine substitutions in the twin Cx9C motifs of COX19 or its interaction partners provide valuable insights into the specific residues mediating these interactions .

What role does COX19 play in mitochondrial stress responses and quality control?

COX19's involvement in mitochondrial stress responses and quality control mechanisms is an emerging area of research:

• Oxidative stress response: The absence of COX19 renders cells particularly susceptible to oxidative damage, similar to the phenotype observed in Cox11 deletion mutants . This hydrogen peroxide sensitivity suggests COX19 contributes to cellular defenses against oxidative stress.

• Protein stabilization function: COX19 appears to stabilize interaction partners like Cox11, as evidenced by decreased Cox19 levels in Δcox11 mitochondria . This stabilization is not due to reduced import rates but rather decreased stability of COX19 in the IMS of Δcox11 mitochondria.

• Protease resistance: Interestingly, COX19 remains barely detectable even when the iAAA-protease Yme1, which is the major protease of the IMS, is deleted in the Δcox11 background . This suggests other quality control mechanisms may regulate COX19 levels.

• Redox signaling: COX19 mediates the transduction of a SCO1-dependent mitochondrial redox signal that regulates ATP7A-mediated cellular copper efflux . This positions COX19 as a critical component in the crosstalk between mitochondrial redox status and cellular copper homeostasis.

• Assembly checkpoint function: The accumulation of specific assembly intermediates in COX19-deficient cells suggests it may function as part of a quality control checkpoint in cytochrome c oxidase biogenesis .

For studying these aspects, researchers should consider combining COX19 antibody-based detection with assays measuring oxidative stress markers, mitochondrial morphology, membrane potential, and protein turnover rates to comprehensively assess COX19's role in mitochondrial quality control.

How can COX19 antibodies be used in studies of human mitochondrial diseases?

COX19 antibodies provide valuable tools for investigating mitochondrial disease mechanisms:

• Patient fibroblast analysis: Examine COX19 levels and localization in fibroblasts from patients with cytochrome c oxidase deficiencies or copper metabolism disorders. Altered COX19 patterns may serve as biomarkers for specific disease mechanisms .

• Genetic complementation studies: Use COX19 antibodies to monitor protein expression in patient cells complemented with wild-type or mutant COX19 to assess functional rescue. These experiments help establish genotype-phenotype correlations and confirm pathogenicity of novel variants.

• Interaction partners in disease contexts: Investigate how disease-causing mutations in related proteins (SCO1, SCO2, COX11) affect interactions with COX19 . SCO1 and SCO2 patient cells show altered steady-state levels of COX19, suggesting these interactions are disrupted in disease states.

• Therapeutic screening applications: Employ COX19 antibodies to monitor protein levels or localization in high-throughput screens for compounds that restore normal mitochondrial function in disease models.

• Tissue-specific expression analysis: Analyze COX19 expression patterns across different tissues in normal and disease states to identify tissue-specific vulnerabilities that might explain clinical presentations of mitochondrial diseases.

When studying COX19 in disease contexts, researchers should consider using multiple cell models including patient-derived fibroblasts, cybrid cell lines constructed using enucleated control fibroblasts and osteosarcoma rho zero cell lines, and CRISPR-engineered knockout models . These diverse models help distinguish primary from secondary effects of disease-causing mutations.

What are the latest techniques for studying dynamic COX19-dependent protein complexes?

Cutting-edge approaches for investigating dynamic COX19-containing complexes include:

• Proximity-dependent biotin labeling: Techniques like BioID or TurboID fused to COX19 enable identification of proximity partners in living cells, capturing even transient interactions. This approach complements traditional co-immunoprecipitation by revealing the wider interaction neighborhood of COX19.

• Single-particle cryo-EM analysis: Apply single-particle cryo-electron microscopy to purified COX19-containing complexes to determine structural arrangements at near-atomic resolution. This helps elucidate how COX19 participates in copper delivery to cytochrome c oxidase.

• Hydrogen-deuterium exchange mass spectrometry (HDX-MS): Use HDX-MS to monitor conformational changes in COX19 and its partners upon complex formation or in response to redox changes. This provides insights into the dynamic structural rearrangements underlying function.

• Native mass spectrometry: Analyze intact protein complexes containing COX19 under native conditions to determine stoichiometry, stability, and metal content of these assemblies.

• Time-resolved crosslinking mass spectrometry: Apply time-resolved crosslinking followed by mass spectrometry to capture the temporal dynamics of COX19-containing complex assembly and disassembly during cytochrome c oxidase biogenesis.

• Super-resolution microscopy: Implement techniques like STORM or PALM to visualize COX19 distribution within mitochondria at nanometer resolution, potentially revealing organizational features not visible by conventional microscopy.

These advanced approaches can be combined with traditional biochemical techniques and COX19 antibody-based detection to provide multilayered insights into COX19 function within dynamic protein complexes.

How do different tissue types and metabolic states affect COX19 expression and function?

The regulation of COX19 across different tissues and metabolic conditions remains an important research frontier:

• Tissue-specific expression patterns: While COX19 is widely expressed, its relative abundance may vary across tissues with different metabolic demands. High-resolution immunohistochemistry using validated COX19 antibodies can map these expression patterns.

• Metabolic adaptation: Investigate how COX19 levels and localization respond to metabolic shifts (e.g., glycolytic versus oxidative phosphorylation predominance) by comparing cells cultured under different nutrient conditions.

• Hypoxia response: Examine COX19 regulation under hypoxic conditions, which are known to affect mitochondrial function and copper metabolism. This may reveal roles in metabolic adaptation to oxygen limitation.

• Integration with nutrient sensing: Explore potential connections between COX19 function and nutrient sensing pathways like mTOR, which coordinate cellular metabolism with mitochondrial biogenesis.

• Developmental regulation: Study COX19 expression during cellular differentiation and development to understand tissue-specific requirements for COX19 in mitochondrial maturation.

• Exercise and muscle metabolism: Investigate COX19 regulation in skeletal muscle in response to exercise, which dramatically increases mitochondrial biogenesis and respiratory capacity.

These studies can incorporate COX19 antibodies for protein detection alongside metabolic flux analysis, respirometry, and in vivo models to comprehensively characterize COX19's role in metabolic adaptation across different physiological contexts.